Simulations Plus, Inc.
NASDAQ:SLPMedical - Healthcare Information Services
+$0.02 today
- Market cap
- $374.16M
- Beta
- 1.32
- P/E (TTM)
- -5.9
- EPS (TTM)
- -$3.12
Volume 0.00M
Average 0.35M
SLP Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Simulations Plus, Inc.NASDAQ: SLP
Depreciation & Amortization · Q2 FY2026 · quarter ended Feb 2026
Depreciation & amortization declines year over year
Q2 FY2026 depreciation & amortization of $1.45M fell 36.3% year over year, behind the -19.3% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 7.6% from the prior quarter. Over 3 fiscal years it compounded at +32.0% a year.
Context
- Depreciation & amortization amounted to 10.4% of revenue in FY2025, up 2.3 pp from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -36.3% toward the trailing-twelve-month pace of -19.3%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 8.21M USD
- Year-over-year change
- +44.9%
- 4-year CAGR
- +23.0%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-08-31 | 8.21M | +44.9% |
| FY2024 | 2024-08-31 | 5.67M | +47.5% |
| FY2023 | 2023-08-31 | 3.84M | +7.4% |
| FY2022 | 2022-08-31 | 3.57M | -0.4% |
| FY2021 | 2021-08-31 | 3.59M | — |
Depreciation & Amortization vs competitors
How SLP compares with its peers on the latest reported figures
- Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -19.3% is the lowest of 11, against a peer median of +12.4%.
- Depreciation & amortization amounts to 8.0% of revenue for SLP, versus a peer median of 23.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $55.54M USD | +5.2% | -0.5% | 23.3% | |
| LTM Mar 2026 | $28.51M USD | +11.8% | +27.6% | 0.5% | |
| LTM Mar 2026 | $19.68M USD | -2.6% | +3.0% | 28.9% | |
| LTM Mar 2026 | $9.98M USD | +13.0% | +19.6% | 12.3% | |
| LTM Mar 2026 | $8.25M USD | +34.9% | +13.0% | 6.0% | |
| LTM Feb 2026 | $6.47M USD | -19.3% | +32.0% | 8.0% | |
| LTM Mar 2026 | $4.3M USD | -1.4% | +28.9% | 4.0% | |
| LTM Mar 2026 | $3.75M USD | -7.8% | +14.7% | 97.6% | |
| LTM Dec 2025 | CHF 2.5M CHF | +15.5% | +0.4% | 69.9% | |
| LTM Mar 2026 | $1.34M USD | +611.6% | +25.6% | 34.2% | |
| LTM Mar 2026 | $674K USD | +14.4% | +24.6% | — | |
| Peer median (excluding SLP) | — | +12.4% | +17.2% | 23.3% | |
Competitors are the stored peer set for SLP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Aug 2021 | FY2022 Aug 2022 | FY2023 Aug 2023 | FY2024 Aug 2024 | FY2025 Aug 2025 |
|---|---|---|---|---|---|
| Net Income | 9.78M | 12.48M | 9.96M | 9.95M | (64.72M) |
| Depreciation & Amortization | 3.59M | 3.57M | 3.84M | 5.67M | 8.21M |
| Deferred Income Tax | (628K) | (270K) | (2.1M) | (1.77M) | (5.43M) |
| Stock-Based Compensation | 2.75M | 3.04M | 4.83M | 6.54M | 6.35M |
| Change in Working Capital | 974K | (2.62M) | 5.1M | (4.21M) | (2.59M) |
| Accounts Receivables | (2.43M) | (3.94M) | 4.1M | 3.13M | (581K) |
| Inventory | 3.15M | 0 | 0 | 0 | 0 |
| Accounts Payables | 39K | (162K) | (81K) | (477K) | (132K) |
| Other Working Capital | 210K | 1.48M | 1.09M | (6.86M) | (1.87M) |
| Other Non-Cash Items | 2.74M | 1.7M | 219K | (2.86M) | 76.29M |
| Operating Cash Flow | 19.2M | 17.9M | 21.86M | 13.32M | 18.13M |
| Capital Expenditures | (4.58M) | (3.97M) | (4.27M) | (566K) | (713K) |
| Acquisitions (Net) | 2.95M | 3.15M | (8.22M) | (98.77M) | 0 |
| Purchases of Investments | (122.4M) | (100.85M) | (95.05M) | (67.16M) | (6.5M) |
| Sales of Investments | 100.23M | 109.12M | 114.91M | 116.27M | 15.01M |
| Other Investing Activities | (2.95M) | (3.15M) | (3.82M) | (3.74M) | (4.24M) |
| Investing Cash Flow | (26.74M) | 4.31M | 7.37M | (53.97M) | 3.56M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 1.46M | 891K | 0 | 731K | 430K |
| Common Stock Repurchased | 0 | 0 | (20M) | 0 | 0 |
| Dividends Paid | (4.81M) | (4.85M) | (4.81M) | (4.8M) | 0 |
| Other Financing Activities | (1.33M) | (3.67M) | 1.54M | (2.5M) | (1.58M) |
| Financing Cash Flow | (4.68M) | (7.62M) | (23.27M) | (6.57M) | (1.15M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (12.22M) | 14.58M | 5.96M | (47.21M) | 20.54M |
| Free Cash Flow | 14.63M | 13.93M | 17.58M | 12.75M | 17.41M |
Simulations Plus, Inc.
NASDAQ:SLP
Intrinsic Alpha fair value
Locked
Current Price
$18.50
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.